Humm Group Ltd HUM Stock Price & News

Finally, UBS Group lowered their price target on Humana from $645.00 to $620.00 and set a “buy” rating on the stock in a report on Thursday, February 2nd. Two research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, Humana has an average rating of “Moderate Buy” and a consensus target price of $594.12. Several equities research analysts have weighed in on the stock.

Deutsche Bank Aktiengesellschaft reduced their price target on shares of Humana from $575.00 to $562.00 and set a “buy” rating for the company in a research report on Tuesday, February 28th. TheStreet cut shares of Humana from a “b” rating to a “c+” rating in a research report on Wednesday, February 1st. Cowen reduced their target price on Humana from $647.00 to $581.00 and set an “outperform” rating for the company in a report on Monday, February 6th.

More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends. Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military’s Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare.

According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $594.12. High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses.

Similar Stocks

SJS Investment Consulting Inc. boosted its stake in shares of Humana by 1,257.1% during the 4th quarter. SJS Investment Consulting Inc. now owns 95 shares of the insurance provider’s stock worth $49,000 after acquiring an additional 88 shares in the last quarter. Affiance Financial LLC acquired a new position in shares of Humana in the 4th quarter worth $50,000. Finally, Accurate Wealth Management LLC purchased a new position in Humana in the 4th quarter worth about $55,000. Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares.

Despite the selling pressure, several rumors made their way across Wall… New York, Oct 4 Automation Anywhere, a leader in cloud-native intelligent automation, on Tuesday unveiled the Automation Success Platform which is designed to accelerate business… Tuesday’s buy puts some of our approximately 10% cash position to work. Humana is exiting the Employer Group Commercial Medical Products business over the next 18 to 24 months. Data are provided ‘as is’ for informational purposes only and are not intended for trading purposes.

The rating they have provided for HUM stocks is “Buy” according to the report published on October 26th, 2022. HUM said Thursday its board has approved a 12.4% increase in its quarterly dividend to 88.50 cents a share from 78.75 last quarter. Shares Sold ShortThe total number of shares of a security that have been sold short and not yet repurchased.Change from LastPercentage change in short interest from the previous report to the most recent report. Exchanges report short interest twice a month.Percent of FloatTotal short positions relative to the number of shares available to trade. A valuation method that multiplies the price of a company’s stock by the total number of outstanding shares. “HUM” stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis.

A stock’s beta measures how closely tied its price movements have been to the performance of the overall market. Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. We see risks for managed care but also opportunities to own moatworthy companies at sizable discounts.

HUM’s Market Performance

Other large investors also recently made changes to their positions in the company. Castleview Partners LLC lifted its stake in Humana by 46,704.0% during the second quarter. Castleview Partners LLC now owns 11,701 shares of the insurance provider’s stock valued at $25,000 after purchasing an additional 11,676 shares during the last quarter. Arlington Partners LLC acquired a new stake in shares of Humana during the 4th quarter valued at $29,000.

Humana will exit its employer group commercial health insurance business to focus on Medicaid, Medicare Advantage and other government-backed business. While Humana currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys. Automotive, tech, and healthcare earnings are out this week as are several Fed reports. Humana has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Reports are indicating that there were more than several insider trading activities at HUM starting from BROUSSARD BRUCE D, who sale 17,575 shares at the price of $505.85 back on Feb 27. After this action, BROUSSARD BRUCE D now owns 70,040 shares of Humana Inc., valued at $8,890,233 using the latest closing price.

: Humana raises quarterly dividend by 12.4% to 88.50 cents a share

The score provides a forward-looking, one-year measure of credit risk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes into account day-to-day movements in market value compared to a company’s liability structure. The Humana 52-week low stock price is 410.87, which is 21% below the current share price. The Humana 52-week high stock price is 571.30, which is 9.9% above the current share price. Humana reported $1.2 billion in third quarter profits largely due to growth in its Medicare Advantage health plans and lower than expected medical expenses. Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on historical, rather than current, valuations.

Recently, Zacks.com users have been paying close attention to Humana . This makes it worthwhile to examine what the stock has in store. Improved premiums cropping from a solid customer base might aid the Medical-HMO industry.

Value remains attractive, but time to rotate back into growth … and even some tech. HUM exceeded the US Healthcare industry which returned -12.5% over the past year. Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. The U.S. Securities and Exchange Commission has received the latest round of 13F filings from Q4, providing retail investors with a complete picture of institutional equity holdings.

The industry with the best average Zacks Rank would be considered the top industry , which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank would place in the bottom 1%. An industry with a larger percentage of Zacks Rank #1’s and #2’s will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4’s and #5’s. Take your analysis to the next level with our full suite of features, known and used by millions throughout the trading world. By Daniel Shvartsman Investing.com – Central Banks and earnings will continue to dominate the week ahead.

https://1investing.in/ inks a 10-year collaboration with Aledade to ensure continued value-based primary care to its Medicare Advantage members from Aledade-backed physicians. The top and bottom-line growth make these Zacks Medical stocks very attractive. By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. One share of HUM stock can currently be purchased for approximately $519.97.

Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters. Humana is a top-tier medical insurer and pays U.S. caregivers to provide services through an integrated and value-based approach while also making the insurance experience easy to navigate for end users. Perhaps not surprisingly, given its founding as a nursing home in the 1960s, Humana places a special focus on serving elderly people, especially in its top-tier position in Medicare Advantage plans. Given U.S. demographic trends and the increasing penetration of Medicare Advantage plans in the eligible population, Humana remains at the forefront of one of the fastest-growing areas in U.S. health insurance.

Based on an average daily trading volume, of 986,600 shares, the days-to-cover ratio is presently 1.9 days. We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

• Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States.
• Market Voice allows investors to share their opinions on stocks.
• Its Masala TV is a food channel mainly catering to Southeast Asia food recipes and is available in the United States, Australia and the Middle East.
• A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

how to use the adx indicator Earnings ESP looks to find companies that have recently seen positive earnings estimate revision activity. The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season. Get the hottest stocks to trade every day before the market opens 100% free. When we switch over and look at the enterprise to sales, we see a ratio of 0.72, with the company’s debt to enterprise value settled at 0.15. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.52.

Huval Timothy S., the Chief Administrative Officer of Humana Inc., sale 2,628 shares at $510.30 during a trade that took place back on Feb 27, which means that Huval Timothy S. Is holding 4,968 shares at $1,341,080 based on the most recent closing price. After a stumble in the market that brought HUM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -10.69% of loss for the given period. By Liz Moyer Investing.com — U.S. stocks wobbled on Thursday after a strong retail sales report and a better than expected number on jobless claims. By Yasin Ebrahim Investing.com — The S&P 500 advanced on Friday, to remain on course for its best week since June, powered by rallying energy and tech stocks amid bets for a less hawkish… By Yasin Ebrahim Investing.com — The Dow closed higher Friday as stocks notched their best week since June, led by energy and tech stocks amid bets for a less hawkish Federal Reserve…